The Medicines Company (MDCO) PT Raised to $60 at Oppenheimer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to The Medicines Company (MDCO) PT Raised to $60 at Oppenheimer

The Medicines Company Presents Results from ORION-11, First Phase 3 Trial of Inclisiran, Showing Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing

September 2, 2019 2:30 AM EDT

-  Inclisiran achieved 54% LDL-C lowering with time-adjusted reductions of 50% sustained over 18 months of treatment

-  ORION-11 study demonstrates inclisirans excellent safety profile, including no treatment-related liver or renal abnormalities

-  Full study results presented during late-breaking science session at ESC Congress 2019

-  The Medicines Company to host investor conference call and webcast on Monday, September 2, 2:00pm CET / 8:00am EDT

... More